Begin main content

dapagliflozin/metformin hydrochloride

Last Updated: December 1, 2015
Result type: Reports
Project Number: SR0468-000
Product Line: Common Drug Review

Generic Name: dapagliflozin/metformin hydrochloride

Brand Name: XigDuo

Manufacturer: AstraZeneca Canada Inc.

Indications: Diabetes Mellitus, Type 2

Submission Type: New

Project Status: Complete

Date Recommendation Issued: July 20, 2016

Recommendation Type: Reimburse with clinical criteria and/or conditions